Semaglutide for Low Back Pain (opens ClinicalTrials.gov)
- Sponsor
- Washington University School of Medicine
- Enrolment
- 250
- Started
- 2027-02-01
- Last update
- 2026-07-28
Conditions: Lower Back Pain, Obesity (BMI>30), Chronic Lower Back Pain, glp1 Agonist
Interventions: Semaglutide (administered by PDS290 pen-injector), Placebo (administered by PDS290 pen-injector)